Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 895 results for "daiichi sankyo"

Daiichi Exits Sun Pharma, Pockets Rs 20,420 crore
New Indian Express

Daiichi Sankyo receives Swissmedic approval for new oral antic...

In the Hokusai-VTE study, once-daily edoxaban 60 mg was non-inferior to warfarin for the primary efficacy endpoint of recurrence of symptomatic VTE (3.2% vs. 3.5% of patients, respectively; HR, 0.89; 95% CI, 0.70 to 1.13, p0.001). In addition, ..., 1 day ago

145 images for daiichi sankyo

Business Today India, 58 minutes ago
Business Today India, 2 days ago
Deccan Chronicle, 2 days ago
NDTV Profit, 3 days ago
Bio Spectrum Asia, 2 days ago
NDTV Profit, 6 hours ago
Financial Express, 2 hours ago
Yahoo! News Australia, 2 days ago
Financial Express, 2 days ago, 3 days ago
India Infoline

Sun Pharma tanks 11% on Daiichi exit

Thanks to Japanese drug maker Daiichi Sankyo’s decision to sell its entire 8.9% stake in Indian pharma major Sun Pharmaceuticals through block deals and at a discount to its market price, the Indian firm’s stock price crashed in early trades by as much as ...
 Times of India4 days ago Sun exit — Daiichi shadow on India  Hindu Business Line4 days ago Daiichi's exit from Sun and its signals of caution  Hindu Business Line4 days ago Sun Pharma slumps on Daiichi exit plan  India Infoline5 days ago

A generic misadventure

Email this Print Daiichi Sankyo has emerged from a long spell of infirmity in India with its financial faculties just about intact. The Japanese group's 2008 purchase of a stake in local drugmaker Ranbaxy was once a fable about overseas expansion ...
 Smart Investor4 days ago Daiichi Sankyo scrubs out Indian M&A nightmare  Hindu Business Line4 days ago

Daiichi salvages $3.2 bn from sunk Ranbaxy investment

Daiichi Sankyo, Japan's second-largest drug manufacturer, has finally made an exit from India after it acquired Ranbaxy Laboratories from the Singh brothers in 2008, bringing an end to its turbulent journey of seven years. On Tuesday, the company offloaded ...
 DNA4 days ago Daiichi salvages $3.2 billion from sunk Ranbaxy investment  DNA India4 days ago

Daiichi Sankyo sells Sun Pharma stake in block deals; stock plunges

By ECONOMICTIMES.COM | 21 Apr, 2015, 09.47AM IST Post a Comment MUMBAI: Shares of Sun Pharmaceuticals were under selling pressure and plunged as much as 10.63 per cent in intraday trade as Daiichi Sankyo offloaded its entire stake in the company through ...
 Economic Times5 days ago Daiichi exits Sun Pharma in block deals; stock ends 9% down  Economic Times4 days ago Japan's Daiichi Sankyo sells Sun Pharma stake  Financial Express4 days ago
Times of India

Stocks to watch in trade today

Sun Pharma: As part of its strategy to exit India, Japanese pharmaceuticals company Daiichi Sankyo will sell its 8.9% in Sun Pharmaceuticals, worth Rs 22,610 crore, in block deals in the stock market on Tuesday. PFC: The state-owned Power Finance ...
 Business Standard India5 days ago Sun Pharma exit may net Daiichi $3.6bn  Times of India5 days ago Daiichi to exit Sun Pharma  Business Standard India5 days ago

Sale size made Daiichi Sankyo opt for bulk deal

Japanese pharma major Daiichi Sankyo exited Sun Pharma for around $3 billion (nearly Rs 20,000 crore) in what was considered as the biggest ever bulk deal in the history of the Indian markets. So what exactly does a bulk deal constitute, and why did Daiichi ...
 Deccan Herald3 days ago
Deccan Chronicle

Sun Pharma share price dives as Daiichi Sankyo says sayonara

Sun Pharmaceuticals share price dived by nearly 9 per cent at the close today in the wake of Japanese pharma company Daiichi Sankyo saying "sayonara" to Indian markets by in the company. The Japanese drug major had received the Sun Pharma shares ...
 Hindu Business Line4 days ago Sun Pharma shares bounce back, up 3 pc on bourses  Business Standard3 days ago Sun Pharma shares bounce back, up by 3 per cent on bourses  Deccan Chronicle3 days ago Sun Pharma shares bounce back, up nearly 2% at close  ZeeNews.com3 days ago

Daiichi Sankyo's misery ends, block deal gives co the final coup de grâc

Even after allowing for control premium, the price that Daiichi Sankyo paid for Ranbaxy Laboratories was clearly excessive, and those in the know said sagely that winner’s curse would have its say sooner than later. The post Daiichi Sankyo’s misery ...
 First Post.com3 days ago

Sun Pharma gains 3%, JP Morgan overweight post massive fall

Shares of Sun Pharma gained 3 percent intraday on Thursday after the massive fall yesterday following Daiichi Sankyo's exit. JP Morgan has an overweight rating on the stock with a target price of Rs 1030 per share. The stock has lost around 19 ...
 Moneycontrol.com3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo
Get updated on latest news & your favorite topics right in your inbox!
More     Less